Global Vancomycin Market Research Report 2022 - Market Size, Current Insights and Development Trends
Vancomycin is a glycopeptide antibiotic used to treat many bacterial infections against antibacterial drugs, treating skin infections, sepsis, endocarditis, bone and joint infections, and meninges caused by methicillin-resistant Staphylococcus aureus. Inflammatory drugs are usually recommended as first-line treatment; when administered, the dose will be adjusted according to the patient's blood concentration.
The report focuses on the Vancomycin market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Vancomycin market.
Major Players in the Vancomycin market are:
Nabriva Therapeutics
Lytix Biopharma
Eli Lilly and Company
Helix BioMedix
MGB Biopharma Limited
Enanta Pharmaceuticals
Pfizer
NovaBay Pharmaceuticals
Alvogen
Zhejiang Pharmaceutical
Taiwan Zhengde Pharmaceutical
Oragenics
LegoChem Biosciences
North China Pharmaceutical
CJ CheilJedang
Zhejiang Haizheng Pharmaceutical
Xellia Pharmaceuticals ApS
NovoBiotic Pharmaceuticals
Sealife Pharma
Microbiotix.
Shenwei Pharmaceutical
Aphios Corporation
VIANEX
Cellceutix Corporation
Alchemia Limited
MicuRx Pharmaceuticals
On the basis of types, the Vancomycin market is primarily split into:
Injectable solution
Powder for injection
On the basis of applications, the market covers:
Sepsis
Lung Infection
Skin Soft Tissue Infection
Colitis & Intestinal Inflammation
To Prevent Infection
Major Regions or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
- 1 Vancomycin Market Overview
- 1.1 Product Overview and Scope of Vancomycin Market
- 1.2 Vancomycin Market Segment by Type
- 1.2.1 Global Vancomycin Market Sales and CAGR (%) Comparison by Type (2017-2029)
- 1.3 Global Vancomycin Market Segment by Application
- 1.3.1 Vancomycin Market Consumption (Sales) Comparison by Application (2017-2029)
- 1.4 Global Vancomycin Market, Region Wise (2017-2029)
- 1.5 Global Market Size (Revenue) of Vancomycin (2017-2029)
- 1.5.1 Global Vancomycin Market Revenue Status and Outlook (2017-2029)
- 1.5.2 Global Vancomycin Market Sales Status and Outlook (2017-2029)
- 1.6 Influence of Regional Conflicts on the Vancomycin Industry
- 1.7 Impact of Carbon Neutrality on the Vancomycin Industry
- 2 Vancomycin Market Upstream and Downstream Analysis
- 2.1 Vancomycin Industrial Chain Analysis
- 2.2 Key Raw Materials Suppliers and Price Analysis
- 2.3 Key Raw Materials Supply and Demand Analysis
- 2.4 Market Concentration Rate of Raw Materials
- 2.5 Manufacturing Process Analysis
- 2.6 Manufacturing Cost Structure Analysis
- 2.6.1 Labor Cost Analysis
- 2.6.2 Energy Costs Analysis
- 2.6.3 R&D Costs Analysis
- 2.7 Major Downstream Buyers of Vancomycin Analysis
- 2.8 Impact of COVID-19 on the Industry Upstream and Downstream
- 3 Players Profiles
- 3.1 Nabriva Therapeutics
- 3.1.1 Nabriva Therapeutics Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.1.2 Product Profiles, Application and Specification
- 3.1.3 Vancomycin Market Performance (2017-2022)
- 3.1.4 Business Overview
- 3.2 Lytix Biopharma
- 3.2.1 Lytix Biopharma Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.2.2 Product Profiles, Application and Specification
- 3.2.3 Vancomycin Market Performance (2017-2022)
- 3.2.4 Business Overview
- 3.3 Eli Lilly and Company
- 3.3.1 Eli Lilly and Company Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.3.2 Product Profiles, Application and Specification
- 3.3.3 Vancomycin Market Performance (2017-2022)
- 3.3.4 Business Overview
- 3.4 Helix BioMedix
- 3.4.1 Helix BioMedix Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.4.2 Product Profiles, Application and Specification
- 3.4.3 Vancomycin Market Performance (2017-2022)
- 3.4.4 Business Overview
- 3.5 MGB Biopharma Limited
- 3.5.1 MGB Biopharma Limited Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.5.2 Product Profiles, Application and Specification
- 3.5.3 Vancomycin Market Performance (2017-2022)
- 3.5.4 Business Overview
- 3.6 Enanta Pharmaceuticals
- 3.6.1 Enanta Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.6.2 Product Profiles, Application and Specification
- 3.6.3 Vancomycin Market Performance (2017-2022)
- 3.6.4 Business Overview
- 3.7 Pfizer
- 3.7.1 Pfizer Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.7.2 Product Profiles, Application and Specification
- 3.7.3 Vancomycin Market Performance (2017-2022)
- 3.7.4 Business Overview
- 3.8 NovaBay Pharmaceuticals
- 3.8.1 NovaBay Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.8.2 Product Profiles, Application and Specification
- 3.8.3 Vancomycin Market Performance (2017-2022)
- 3.8.4 Business Overview
- 3.9 Alvogen
- 3.9.1 Alvogen Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.9.2 Product Profiles, Application and Specification
- 3.9.3 Vancomycin Market Performance (2017-2022)
- 3.9.4 Business Overview
- 3.10 Zhejiang Pharmaceutical
- 3.10.1 Zhejiang Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.10.2 Product Profiles, Application and Specification
- 3.10.3 Vancomycin Market Performance (2017-2022)
- 3.10.4 Business Overview
- 3.11 Taiwan Zhengde Pharmaceutical
- 3.11.1 Taiwan Zhengde Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.11.2 Product Profiles, Application and Specification
- 3.11.3 Vancomycin Market Performance (2017-2022)
- 3.11.4 Business Overview
- 3.12 Oragenics
- 3.12.1 Oragenics Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.12.2 Product Profiles, Application and Specification
- 3.12.3 Vancomycin Market Performance (2017-2022)
- 3.12.4 Business Overview
- 3.13 LegoChem Biosciences
- 3.13.1 LegoChem Biosciences Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.13.2 Product Profiles, Application and Specification
- 3.13.3 Vancomycin Market Performance (2017-2022)
- 3.13.4 Business Overview
- 3.14 North China Pharmaceutical
- 3.14.1 North China Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.14.2 Product Profiles, Application and Specification
- 3.14.3 Vancomycin Market Performance (2017-2022)
- 3.14.4 Business Overview
- 3.15 CJ CheilJedang
- 3.15.1 CJ CheilJedang Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.15.2 Product Profiles, Application and Specification
- 3.15.3 Vancomycin Market Performance (2017-2022)
- 3.15.4 Business Overview
- 3.16 Zhejiang Haizheng Pharmaceutical
- 3.16.1 Zhejiang Haizheng Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.16.2 Product Profiles, Application and Specification
- 3.16.3 Vancomycin Market Performance (2017-2022)
- 3.16.4 Business Overview
- 3.17 Xellia Pharmaceuticals ApS
- 3.17.1 Xellia Pharmaceuticals ApS Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.17.2 Product Profiles, Application and Specification
- 3.17.3 Vancomycin Market Performance (2017-2022)
- 3.17.4 Business Overview
- 3.18 NovoBiotic Pharmaceuticals
- 3.18.1 NovoBiotic Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.18.2 Product Profiles, Application and Specification
- 3.18.3 Vancomycin Market Performance (2017-2022)
- 3.18.4 Business Overview
- 3.19 Sealife Pharma
- 3.19.1 Sealife Pharma Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.19.2 Product Profiles, Application and Specification
- 3.19.3 Vancomycin Market Performance (2017-2022)
- 3.19.4 Business Overview
- 3.20 Microbiotix.
- 3.20.1 Microbiotix. Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.20.2 Product Profiles, Application and Specification
- 3.20.3 Vancomycin Market Performance (2017-2022)
- 3.20.4 Business Overview
- 3.21 Shenwei Pharmaceutical
- 3.21.1 Shenwei Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.21.2 Product Profiles, Application and Specification
- 3.21.3 Vancomycin Market Performance (2017-2022)
- 3.21.4 Business Overview
- 3.22 Aphios Corporation
- 3.22.1 Aphios Corporation Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.22.2 Product Profiles, Application and Specification
- 3.22.3 Vancomycin Market Performance (2017-2022)
- 3.22.4 Business Overview
- 3.23 VIANEX
- 3.23.1 VIANEX Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.23.2 Product Profiles, Application and Specification
- 3.23.3 Vancomycin Market Performance (2017-2022)
- 3.23.4 Business Overview
- 3.24 Cellceutix Corporation
- 3.24.1 Cellceutix Corporation Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.24.2 Product Profiles, Application and Specification
- 3.24.3 Vancomycin Market Performance (2017-2022)
- 3.24.4 Business Overview
- 3.25 Alchemia Limited
- 3.25.1 Alchemia Limited Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.25.2 Product Profiles, Application and Specification
- 3.25.3 Vancomycin Market Performance (2017-2022)
- 3.25.4 Business Overview
- 3.26 MicuRx Pharmaceuticals
- 3.26.1 MicuRx Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.26.2 Product Profiles, Application and Specification
- 3.26.3 Vancomycin Market Performance (2017-2022)
- 3.26.4 Business Overview
- 4 Global Vancomycin Market Landscape by Player
- 4.1 Global Vancomycin Sales and Share by Player (2017-2022)
- 4.2 Global Vancomycin Revenue and Market Share by Player (2017-2022)
- 4.3 Global Vancomycin Average Price by Player (2017-2022)
- 4.4 Global Vancomycin Gross Margin by Player (2017-2022)
- 4.5 Vancomycin Market Competitive Situation and Trends
- 4.5.1 Vancomycin Market Concentration Rate
- 4.5.2 Vancomycin Market Share of Top 3 and Top 6 Players
- 4.5.3 Mergers & Acquisitions, Expansion
- 5 Global Vancomycin Sales, Revenue, Price Trend by Type
- 5.1 Global Vancomycin Sales and Market Share by Type (2017-2022)
- 5.2 Global Vancomycin Revenue and Market Share by Type (2017-2022)
- 5.3 Global Vancomycin Price by Type (2017-2022)
- 5.4 Global Vancomycin Sales, Revenue and Growth Rate by Type (2017-2022)
- 5.4.1 Global Vancomycin Sales, Revenue and Growth Rate of Injectable solution (2017-2022)
- 5.4.2 Global Vancomycin Sales, Revenue and Growth Rate of Powder for injection (2017-2022)
- 6 Global Vancomycin Market Analysis by Application
- 6.1 Global Vancomycin Consumption and Market Share by Application (2017-2022)
- 6.2 Global Vancomycin Consumption Revenue and Market Share by Application (2017-2022)
- 6.3 Global Vancomycin Consumption and Growth Rate by Application (2017-2022)
- 6.3.1 Global Vancomycin Consumption and Growth Rate of Sepsis (2017-2022)
- 6.3.2 Global Vancomycin Consumption and Growth Rate of Lung Infection (2017-2022)
- 6.3.3 Global Vancomycin Consumption and Growth Rate of Skin Soft Tissue Infection (2017-2022)
- 6.3.4 Global Vancomycin Consumption and Growth Rate of Colitis & Intestinal Inflammation (2017-2022)
- 6.3.5 Global Vancomycin Consumption and Growth Rate of To Prevent Infection (2017-2022)
- 7 Global Vancomycin Sales and Revenue Region Wise (2017-2022)
- 7.1 Global Vancomycin Sales and Market Share, Region Wise (2017-2022)
- 7.2 Global Vancomycin Revenue and Market Share, Region Wise (2017-2022)
- 7.3 Global Vancomycin Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.4 United States Vancomycin Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.5 Europe Vancomycin Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.6 China Vancomycin Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.7 Japan Vancomycin Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.8 India Vancomycin Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.9 Southeast Asia Vancomycin Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.10 Latin America Vancomycin Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.11 Middle East and Africa Vancomycin Sales, Revenue, Price and Gross Margin (2017-2022)
- 8 Global Vancomycin Market Forecast (2022-2029)
- 8.1 Global Vancomycin Sales, Revenue Forecast (2022-2029)
- 8.1.1 Global Vancomycin Sales and Growth Rate Forecast (2022-2029)
- 8.1.2 Global Vancomycin Revenue and Growth Rate Forecast (2022-2029)
- 8.1.3 Global Vancomycin Price and Trend Forecast (2022-2029)
- 8.2 Global Vancomycin Sales and Revenue Forecast, Region Wise (2022-2029)
- 8.2.1 United States Vancomycin Sales and Revenue Forecast (2022-2029)
- 8.2.2 Europe Vancomycin Sales and Revenue Forecast (2022-2029)
- 8.2.3 China Vancomycin Sales and Revenue Forecast (2022-2029)
- 8.2.4 Japan Vancomycin Sales and Revenue Forecast (2022-2029)
- 8.2.5 India Vancomycin Sales and Revenue Forecast (2022-2029)
- 8.2.6 Southeast Asia Vancomycin Sales and Revenue Forecast (2022-2029)
- 8.2.7 Latin America Vancomycin Sales and Revenue Forecast (2022-2029)
- 8.2.8 Middle East and Africa Vancomycin Sales and Revenue Forecast (2022-2029)
- 8.3 Global Vancomycin Sales, Revenue and Price Forecast by Type (2022-2029)
- 8.3.1 Global Vancomycin Revenue and Growth Rate of Injectable solution (2022-2029)
- 8.3.2 Global Vancomycin Revenue and Growth Rate of Powder for injection (2022-2029)
- 8.4 Global Vancomycin Consumption Forecast by Application (2022-2029)
- 8.4.1 Global Vancomycin Consumption Value and Growth Rate of Sepsis (2022-2029)
- 8.4.2 Global Vancomycin Consumption Value and Growth Rate of Lung Infection (2022-2029)
- 8.4.3 Global Vancomycin Consumption Value and Growth Rate of Skin Soft Tissue Infection (2022-2029)
- 8.4.4 Global Vancomycin Consumption Value and Growth Rate of Colitis & Intestinal Inflammation (2022-2029)
- 8.4.5 Global Vancomycin Consumption Value and Growth Rate of To Prevent Infection (2022-2029)
- 8.5 Vancomycin Market Forecast Under COVID-19
- 9 Industry Outlook
- 9.1 Vancomycin Market Drivers Analysis
- 9.2 Vancomycin Market Restraints and Challenges
- 9.3 Vancomycin Market Opportunities Analysis
- 9.4 Emerging Market Trends
- 9.5 Vancomycin Industry Technology Status and Trends
- 9.6 News of Product Release
- 9.7 Consumer Preference Analysis
- 9.8 Vancomycin Industry Development Trends under COVID-19 Outbreak
- 9.8.1 Global COVID-19 Status Overview
- 9.8.2 Influence of COVID-19 Outbreak on Vancomycin Industry Development
- 10 Research Findings and Conclusion
- 11 Appendix
- 11.1 Methodology
- 11.2 Research Data Source
- 1.2 Vancomycin Market Segment by Type
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook